10 August 2019 - A federal government move to lower drug prices is winning praise from some patient advocates but sparking concerns that it will dampen research into pioneering new medicines and exacerbate a potential drug shortage at a time when American states are looking to Canada for their drug supplies.

Health Canada on Friday unveiled changes to give an independent watchdog better tools in its job to keep vigil over the price of patented medicines in Canada.

It is billed as the most substantive changes in three decades, and the government says it will mean savings of more than $13 billion over the next decade. And the changes are seen as a critical step toward a pharmacare program for Canada.

Read Toronto Star article